阳性血培养肉汤细菌核酸提取优化方法用于全基因组测序、耐药表型预测及下游分子应用
该研究前瞻性收集40份生长革兰阴性菌的血培养肉汤样本,比较不同商业试剂盒提取DNA的效果,并评估直接宏基因组测序鉴定菌种及机器学习算法预测药敏的可行性。结果显示两试剂盒法提取效果最佳,测序鉴定与常规法一致率为95%,药敏预测总体分类一致率为95%。
要点
- 两试剂盒法(MolYsis Basic与Qiagen DNeasy UltraClean)可获得最佳DNA提取效果。
- 直接宏基因组测序鉴定与常规法一致率为95%(38/40)。
- 药敏预测对6种常见病原菌针对17种抗生素的总体分类一致率为95%。
核心结论
- 从血培养肉汤直接进行宏基因组测序用于病原检测和耐药预测是可行的。
- 需进一步优化罕见菌种和复杂耐药基因型的算法,并简化流程以提供更快速的结果。
研究设计与样本
- 前瞻性收集40份生长革兰阴性菌的血培养肉汤样本,使用商业试剂盒提取DNA。
- 比较直接宏基因组测序鉴定和机器学习算法(AREScloud)药敏预测与常规方法及其他快速诊断平台(Accelerate Pheno和BCID panel)的一致性。
主要发现
- 两试剂盒法(MolYsis Basic和Qiagen DNeasy UltraClean)获得最佳提取效果。
- 直接宏基因组测序分类谱与常规鉴定在38/40(95%)样本中一致;2份混合感染样本中第二种微生物被漏检。
- 预测模型能准确推断6种常见病原菌对17种抗生素的药敏谱,总体分类一致率为95%;若排除产酸克雷伯菌,5/6最常见病原菌的分类一致率>95%。
- 全基因组测序药敏试验对罕见病原菌(如伊丽莎白菌)和某些β-内酰胺酶抑制剂抗生素(如替卡西林-克拉维酸)表现欠佳。
- BCID从血培养阳性到病原鉴定最快(1小时);Accelerate Pheno约8小时提供药敏结果;基于Illumina的直接测序方法结果时间与传统培养法相似。
关键数值与推荐
- 直接宏基因组测序鉴定与常规法一致率为95%(38/40)。
- 药敏预测总体分类一致率为95%,排除产酸克雷伯菌后5/6最常见病原菌分类一致率>95%。
- BCID鉴定时间1小时,Accelerate Pheno药敏时间约8小时。
临床怎么用
- 对于生长革兰阴性菌的阳性血培养肉汤,可采用两试剂盒法提取DNA进行直接宏基因组测序和耐药预测。
- 该方法对常见病原菌药敏预测准确性较高,但罕见菌和部分β-内酰胺酶抑制剂抗生素结果需谨慎解读。
局限性
- 混合感染样本中第二种微生物可能被测序漏检。
- 对罕见病原菌和某些β-内酰胺酶抑制剂抗生素的药敏预测性能欠佳。
- 直接测序方法结果时间与传统培养法相似,未显著缩短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The application of direct metagenomic sequencing from positive blood culture broth may solve the challenges of sequencing from low-bacterial-load blood samples in patients with sepsis. Forty prospectively collected blood culture broth samples growing Gram-negative bacteria were extracted using commercially available kits to achieve high-quality DNA. Species identification via metagenomic sequencing and susceptibility prediction via a machine-learning algorithm (AREScloud) were compared to conventional methods and other rapid diagnostic platforms (Accelerate Pheno and blood culture identification [BCID] panel). A two-kit method (using MolYsis Basic and Qiagen DNeasy UltraClean kits) resulted in optimal extractions. Taxonomic profiling by direct metagenomic sequencing matched conventional identification in 38/40 (95%) samples. In two polymicrobial samples, a second organism was missed by sequencing. Prediction models were able to accurately infer susceptibility profiles for 6 common pathogens against 17 antibiotics, with an overall categorical agreement (CA) of 95% (increasing to >95% for 5/6 of the most common pathogens, if Klebsiella oxytoca was excluded). The performance of whole-genome sequencing (WGS)-antimicrobial susceptibility testing (AST) was suboptimal for uncommon pathogens (e.g., Elizabethkingia) and some β-lactamase inhibitor antibiotics (e.g., ticarcillin-clavulanate). The time to pathogen identification was the fastest with BCID (1 h from blood culture positivity). Accelerate Pheno provided a susceptibility result in approximately 8 h. Illumina-based direct sequencing methods provided results in time frames similar to those of conventional culture-based methods. Direct metagenomic sequencing from blood cultures for pathogen detection and susceptibility prediction is feasible. Additional work is required to optimize algorithms for uncommon species and complex resistance genotypes as well as to streamline methods to provide more rapid results.
引用
- Bauer MJ, Peri AM, Lüftinger L, et al. Optimized Method for Bacterial Nucleic Acid Extraction from Positive Blood Culture Broth for Whole-Genome Sequencing, Resistance Phenotype Prediction, and Downstream Molecular Applications. J Clin Microbiol. 2022. PMID: 36314799. doi:10.1128/jcm.01012-22
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。